Literature DB >> 17012857

Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination.

J Diez-Domingo1, A Gil, M San-Martín, A González, J Esteban, J M Baldó, M V Planelles, M I Ubeda, M Graullera, A Peris, M Martínez, V Antón, D Gallego, T Alvarez, J V Villarroya, A Jubert, C Casaní, C Peidró, M García, A Ballester.   

Abstract

This study assessed the seroprevalence of varicella antibodies in children and adolescents in Spain and evaluated the reliability of two methods for detecting susceptible individuals: (1) parental-reported history of varicella and (2) medically-documented histories maintained by the pediatrician. A total of 186 children (6 to 15 years of age) were recruited in 13 pediatric offices of Valencia, Spain. A brief case report form was completed including previous history of varicella referred by the parents, and a 5 mL blood sample was obtained. The pediatrician medical file was reviewed for antecedent of varicella. The overall prevalence of varicella antibodies was 84% and 88% in the 6-9 years and 10-15 years age brackets, respectively. The predictive value of a negative history of varicella disease was 48% by parental recall (52% "false negative"), and only 26% by medical record (74% "false negative"). However, the positive predictive value of a positive parental reported history or a positive medically-documented history was 95%. The most effective strategy for varicella vaccination of older children and adolescents in Spain will be to immunize those individuals with a lack of positive (unknown or negative) history of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17012857     DOI: 10.4161/hv.1.5.2216

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  5 in total

1.  Vaccination campaign at a temporary camp for victims of the earthquake in Lorca (Spain).

Authors:  Jaime Jesús Pérez-Martín; Francisco José Romera Guirado; Yolanda Molina-Salas; Pedro José Bernal-González; José Antonio Navarro-Alonso
Journal:  Hum Vaccin Immunother       Date:  2017-03-31       Impact factor: 3.452

2.  Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).

Authors:  Lluís Salleras; Angela Domínguez; Pere Plans; Josep Costa; Neus Cardeñosa; Núria Torner; Antoni Plasència
Journal:  Med Microbiol Immunol       Date:  2007-11-15       Impact factor: 4.148

3.  The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.

Authors:  Judith H Wolleswinkel-van den Bosch; Anouk M Speets; Hans C Rümke; Pearl D Gumbs; Sander C Fortanier
Journal:  BMC Infect Dis       Date:  2011-11-17       Impact factor: 3.090

4.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

5.  Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Authors:  Nigel Field; Gayatri Amirthalingam; Pauline Waight; Nick Andrews; Shamez N Ladhani; Albert Jan van Hoek; Peter A C Maple; Kevin E Brown; Elizabeth Miller
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.